94, PER 5.83 42 (LAM9) 32 (7.19) 1.26 AMER-S 30.62, AMER-N 16.71, Sapanisertib supplier EURO-S 13.12, EURO-W 7.21, AFRI-N 5.20 USA 15.65, BRA 10.60, COL 8.08, ITA 6.90 48 (EAI1-SOM) 30 (6.74) 7.89 EURO-N 26.32, ASIA-S 21.32, EURO-W 15.00, AFRI-E 10.00, AFRI-S 9.47, ASIA-SE 5.00 DNK 15.53, BGD 14.21, NLD 12.37, ZAF 9.47, MOZ 8.95, IND 6.05, GBR 5.26 53 (T1) 9 (2.02) 0.19 AMER-N 19.91, AMER-S 14.64, EURO-W 12.97, EURO-S 10.14, ASIA-W 8.79, AFRI-S 6.03 USA 17.54, ZAF 5.89, ITA 5.19 59 (LAM11-ZWE) 13 (2.92) 3.39 AFRI-E 67.89, AFRI-S 19.06 ZMB 27.68, ZWE 20.10, ZAF 19.06, TZA 8.36 73 (T2) 8 (1.80) 4.15
AMER-N 21.24, EURO-S 19.69, AFRI-S 13.47, EURO-W 12.44, AMER-S 10.36, AFRI-E 7.25 USA 18.65, ITA 17.62, ZAF 13.47, MOZ 5.18 92 (X3) 9 (2.02) 2.34 GDC 0032 clinical trial AFRI-S 49.09, Selleckchem Epacadostat AMER-N 24.42, AMER-S 9.61, EURO-N 5.19 ZAF 49.09, USA 21.82, BRA 5.71 129 (EAI6-BGD1) 14 (3.15) 35.90 AFRI-E 58.97, AMER-S 12.82, AMER-N 12.82, EURO-W 5.13, AFRI-N 5.13 MOZ 38.46, USA 12.82, GUF 10.26, MWI 10.26, TUN 5.13 150 (LAM9) 11 (2.47) 12.36 EURO-W 33.71, AMER-S 23.60, EURO-S 17.98, AFRI-E 13.48 BEL 24.72, MOZ 12.36, PRT 10.11, FXX 8.99, BRA
8.99, ITA 6.74, ARG 6.74, VEN 5.62 702 (EAI6-BGD1) 11 (2.47) 34.38 AFRI-E 71.88, AMER-S 15.62, CARI 6.25 MOZ 34.38, MWI 28.12, BRA 12.50, ZMB 9.38, CUB 6.25 806 (EAI1-SOM) 13 (2.92) 26.53 AFRI-S 44.90, AFRI-E 34.69, AMER-N 16.33 ZAF 44.90, MOZ 30.61, USA 16.33 811 (LAM11-ZWE) 14 (3.15) 26.92 AFRI-E 51.92, AFRI-S 38.46, AMER-N 9.62 ZAF 38.46, MOZ 28.85, ZWE 15.38, USA 9.62 815 (LAM11-ZWE) 9 (2.02) 7.83 AFRI-E 73.91, AFRI-S 21.74 ZMB 54.78, ZAF 21.74, ZWE 7.83, MOZ 7.83 * Worldwide distribution is reported for regions with ≥5% of a given SITs as compared to their total number in the SITVIT2 database. Furthermore, CARIB (Caribbean) belongs to Americas, while Oceania is subdivided in 4 sub-regions, AUST (Australasia), MEL (Melanesia), MIC (Micronesia), and POLY (Polynesia). Note that in our classification scheme, Y-27632 2HCl Russia has been attributed a new sub-region by itself (Northern Asia) instead of including it among rest of the Eastern Europe. It reflects its geographical localization as well as due to the similarity of specific TB genotypes circulating in Russia (a majority of Beijing genotypes) with those prevalent in Central, Eastern and South-Eastern Asia.